Cambridge Major Laboratories and AAIPharma Appoint CEO of Merged Company

Published on: 

Cambridge Major Laboratories and AAIPharma Services appoints Patrick D. Walsh as CEO of merged company.

Cambridge Major Laboratories, a provider of pharmaceutical API development and manufacturing, and the CDMO/CMO AAIPharma Services have appointed Patrick D. Walsh as the CEO of the merged company. In October 2013, Cambridge and AAIPharma announced their intent to merge. The combined company forms a supplier of integrated chemistry manufacturing and control (CMC) services, including process chemistry, solid state chemistry, API manufacturing, formulation development, analytical development and testing services, clinical and commercial finished dosage-form manufacturing (oral solid and sterile), and packaging and stability services.

Source: AAIPharma Service